Figure 5.Comparison of ESTIMATE between high-risk and low-risk groups. (A, B) Tumor purity, stromal score, and immune score of different groups were evaluated by ESTIMATE. (C). Comparison of TIICs levels between two groups (ANOVA test).
Figure 5 — A prognostic model for melanoma patients on the basis of immune-related lncRNAs | Aging
